- In March 2025, Surgicure Technologies announced the closing of a USD 1.785 million Seed funding round to accelerate the commercialization of its Horseshoe product, designed to revolutionize airway management. This development underscores Surgicure's commitment to advancing patient safety and optimizing breathing support by replacing outdated methods and reducing adverse events in critical care settings
- In December 2024, Inogen, Inc. announced it received U.S. Food and Drug Administration (FDA) 510(k) clearance for the SIMEOX 200 Airway Clearance Device. This development underscores Inogen's commitment to expanding its offerings for patients with chronic respiratory diseases by providing an innovative solution designed to promote bronchial drainage and mobilize secretions in the homecare setting
- In March 2024, Asahi Kasei Medical and AW Technologies announced an exclusive distribution agreement for AW Technologies’ TrachFlush device in Japan. This partnership underscores their commitment to advancing airway management by introducing a novel solution designed to reduce patient discomfort and lighten the workload on healthcare professionals during tracheal suctioning
